The government on Wednesday said the production and supply of critical anti-viral drug Remdesivir will be increased in the country amid the rising COVID-19 cases. The government met Remdesivir manufacturers who volunteered to reduce the price to less than ₹3,500 per vial by the end of this week. Fast-track approval has been given for seven more sites to manufacture Remdesivir.